These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 16517820)
1. Effects of stage and number of tumours on prognosis of dogs with cutaneous mast cell tumours. Murphy S; Sparkes AH; Blunden AS; Brearley MJ; Smith KC Vet Rec; 2006 Mar; 158(9):287-91. PubMed ID: 16517820 [TBL] [Abstract][Full Text] [Related]
2. Chlorambucil and prednisolone chemotherapy for dogs with inoperable mast cell tumours: 21 cases. Taylor F; Gear R; Hoather T; Dobson J J Small Anim Pract; 2009 Jun; 50(6):284-9. PubMed ID: 19527421 [TBL] [Abstract][Full Text] [Related]
3. Relationships between the histological grade of cutaneous mast cell tumours in dogs, their survival and the efficacy of surgical resection. Murphy S; Sparkes AH; Smith KC; Blunden AS; Brearley MJ Vet Rec; 2004 Jun; 154(24):743-6. PubMed ID: 15224593 [TBL] [Abstract][Full Text] [Related]
4. Cytological lymph node evaluation in dogs with mast cell tumours: association with grade and survival. Krick EL; Billings AP; Shofer FS; Watanabe S; Sorenmo KU Vet Comp Oncol; 2009 Jun; 7(2):130-8. PubMed ID: 19453367 [TBL] [Abstract][Full Text] [Related]
5. Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours. Kiupel M; Webster JD; Miller RA; Kaneene JB J Vet Med A Physiol Pathol Clin Med; 2005 Aug; 52(6):280-6. PubMed ID: 16050909 [TBL] [Abstract][Full Text] [Related]
6. Results of radiation therapy in 19 dogs with cutaneous mast cell tumor and regional lymph node metastasis. Chaffin K; Thrall DE Vet Radiol Ultrasound; 2002; 43(4):392-5. PubMed ID: 12175005 [TBL] [Abstract][Full Text] [Related]
7. Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs. Patnaik AK; Ehler WJ; MacEwen EG Vet Pathol; 1984 Sep; 21(5):469-74. PubMed ID: 6435301 [TBL] [Abstract][Full Text] [Related]
8. The prognostic value of lymph node metastasis with grade 2 MCTs in dogs: 55 cases (2001-2010). Baginski H; Davis G; Bastian RP J Am Anim Hosp Assoc; 2014; 50(2):89-95. PubMed ID: 24446400 [TBL] [Abstract][Full Text] [Related]
9. Biologic behavior and prognostic factors for mast cell tumors of the canine muzzle: 24 cases (1990-2001). Gieger TL; Théon AP; Werner JA; McEntee MC; Rassnick KM; DeCock HE J Vet Intern Med; 2003; 17(5):687-92. PubMed ID: 14529136 [TBL] [Abstract][Full Text] [Related]
10. Prognosis following surgical excision of canine cutaneous mast cell tumors with histopathologically tumor-free versus nontumor-free margins: a retrospective study of 31 cases. Michels GM; Knapp DW; DeNicola DB; Glickman N; Bonney P J Am Anim Hosp Assoc; 2002; 38(5):458-66. PubMed ID: 12220031 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical and clinical evaluation of p53 in canine cutaneous mast cell tumors. Jaffe MH; Hosgood G; Taylor HW; Kerwin SC; Hedlund CS; Lopez MK; Davidson JR; Miller DM; Paranjpe M Vet Pathol; 2000 Jan; 37(1):40-6. PubMed ID: 10643979 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical detection of p53 tumor-suppressor protein is a poor indicator of prognosis for canine cutaneous mast cell tumors. Ginn PE; Fox LE; Brower JC; Gaskin A; Kurzman ID; Kubilis PS Vet Pathol; 2000 Jan; 37(1):33-9. PubMed ID: 10643978 [TBL] [Abstract][Full Text] [Related]
14. Outcomes of dogs with grade 3 mast cell tumors: 43 cases (1997-2007). Hume CT; Kiupel M; Rigatti L; Shofer FS; Skorupski KA; Sorenmo KU J Am Anim Hosp Assoc; 2011; 47(1):37-44. PubMed ID: 21164163 [TBL] [Abstract][Full Text] [Related]
15. Prognostic factors for radiation treatment of mast cell tumor in 85 dogs. Turrel JM; Kitchell BE; Miller LM; Théon A J Am Vet Med Assoc; 1988 Oct; 193(8):936-40. PubMed ID: 3142828 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of radiation therapy for incompletely resected grade-III mast cell tumors in dogs: 31 cases (1987-1998). Hahn KA; King GK; Carreras JK J Am Vet Med Assoc; 2004 Jan; 224(1):79-82. PubMed ID: 14710881 [TBL] [Abstract][Full Text] [Related]
17. Use of histologic margin evaluation to predict recurrence of cutaneous malignant tumors in dogs and cats after surgical excision. Scarpa F; Sabattini S; Marconato L; Capitani O; Morini M; Bettini G J Am Vet Med Assoc; 2012 May; 240(10):1181-7. PubMed ID: 22559107 [TBL] [Abstract][Full Text] [Related]
18. Histologically low-grade, yet biologically high-grade, canine cutaneous mast cell tumours: A systematic review and meta-analysis of individual participant data. Bae S; Milovancev M; Bartels C; Irvin VL; Tuohy JL; Townsend KL; Leeper H Vet Comp Oncol; 2020 Dec; 18(4):580-589. PubMed ID: 32103587 [TBL] [Abstract][Full Text] [Related]
19. Cytologic Criteria for Mast Cell Tumor Grading in Dogs With Evaluation of Clinical Outcome. Camus MS; Priest HL; Koehler JW; Driskell EA; Rakich PM; Ilha MR; Krimer PM Vet Pathol; 2016 Nov; 53(6):1117-1123. PubMed ID: 27034386 [TBL] [Abstract][Full Text] [Related]
20. Characterisation of the signalment, clinical and survival characteristics of 41 cats with mast cell neoplasia. Litster AL; Sorenmo KU J Feline Med Surg; 2006 Jun; 8(3):177-83. PubMed ID: 16476559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]